Alterations in caveolin-1 expression and receptor-operated ca2+ entry in the aortas of rats with pulmonary hypertension

Cellular Physiology and Biochemistry

Volumn 39, Issue 2, 2016, Pages 438-452

  Mu, Yun Ping ^a   Lin, Da Cen ^a   Yan, Fu Rong ^a   Jiao, Hai Xia ^a   Gui, Long Xin ^a   Lin, Mo Jun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Aortas; Caveolae; Caveolin 1; Pulmonary hypertension; Receptor operated calcium entry

Indexed keywords

1 OLEOYL 2 ACETYL SN GLYCEROL; CALCIUM CHANNEL; CAVEOLIN 1; CHOLESTEROL; CYCLOPIAZONIC ACID; ENDOTHELIN 1; GLYCEROL; MESSENGER RNA; PHENYLEPHRINE; POTASSIUM CHLORIDE; RECEPTOR OPERATED CALCIUM CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG; CALCIUM; CELL SURFACE RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPC6 PROTEIN, RAT; VASOCONSTRICTOR AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; AORTA SMOOTH MUSCLE CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CAVEOLA; CONCENTRATION PROCESS; CONTROLLED STUDY; HEART LEFT VENTRICLE MASS; HISTOPATHOLOGY; IN VITRO STUDY; LEFT VENTRICULAR SYSTOLIC PRESSURE; MALE; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE CELL; SYSTOLIC BLOOD PRESSURE; ANIMAL; AORTA; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASOCONSTRICTION; WESTERN BLOTTING;

ANIMALS; AORTA; BLOTTING, WESTERN; CALCIUM; CAVEOLAE; CAVEOLIN 1; CELLS, CULTURED; GENE EXPRESSION; HYPERTENSION, PULMONARY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, SMOOTH MUSCLE; PHENYLEPHRINE; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRPC CATION CHANNELS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84978091743     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000445637     Document Type: Article

References (63)

1. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX: Cellular and molecular mechanisms of pulmonary vascular remodeling: Role in the development of pulmonary hypertension. Microvasc Res 2004;68:75-103.
2. Firth AL, Won JY, Park WS: Regulation of Ca2+ signaling in pulmonary hypertension. Korean J Physiol Pharmacol 2013;17:1-8.
3. Parton RG, del Pozo MA: Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 2013;14:98-112.
4. Chidlow JH, Jr., Sessa WC: Caveolae, caveolins, and cavins: Complex control of cellular signalling and inflammation. Cardiovasc Res 2010;86:219-225.
5. Sathish V, Yang B, Meuchel LW, VanOosten SK, Ryu AJ, Thompson MA, Prakash YS, Pabelick CM: Caveolin-1 and force regulation in porcine airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2011;300:L920-929.
6. Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC: Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am J Respir Crit Care Med 2010;182:261-268.
7. Fish JE, Matouk CC, Yeboah E, Bevan SC, Khan M, Patil K, Ohh M, Marsden PA: Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase. J Biol Chem 2007;282:15652-15666.
8. Liu P, Rudick M, Anderson RG: Multiple functions of caveolin-1. J Biol Chem 2002;277:41295-41298.
9. Kuhr FK, Smith KA, Song MY, Levitan I, Yuan JX: New mechanisms of pulmonary arterial hypertension: Role of Ca2+ signaling. Am J Physiol Heart Circ Physiol 2012;302:H1546-1562.
10. Prieto-Lloret J, Aaronson PI: Intracellular remodelling of Ca2+ stores in pulmonary hypertension. Cardiovasc Res 2014;103:189-191.
11. Jernigan NL, Resta TC: Calcium homeostasis and sensitization in pulmonary arterial smooth muscle. Microcirculation 2014;21:259-271.
12. Guo Q, Huang JA, Yamamura A, Yamamura H, Zimnicka AM, Fernandez R, Yuan JX: Inhibition of the Ca2+-sensing receptor rescues pulmonary hypertension in rats and mice. Hypertens Res 2014;37:116-124.
13. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV: Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001;293:2449-2452.
14. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J, Jr., Chien KR: Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 2002;99:11375-11380.
15. Patel HH, Tsutsumi YM, Head BP, Niesman IR, Jennings M, Horikawa Y, Huang D, Moreno AL, Patel PM, Insel PA, Roth DM: Mechanisms of cardiac protection from ischemia/reperfusion injury: A role for caveolae and caveolin-1. FASEB J 2007;21:1565-1574.
16. Huber LC, Soltermann A, Fischler M, Gay S, Weder W, Russi EW, Speich R, Ulrich S: Caveolin-1 expression and hemodynamics in copd patients. Open Respir Med J 2009;3:73-78.
17. Sathish V, Abcejo AJ, Thompson MA, Sieck GC, Prakash YS, Pabelick CM: Caveolin-1 regulation of store-operated Ca2+ influx in human airway smooth muscle. Eur Respir J 2012;40:470-478.
18. Huang J, Wolk JH, Gewitz MH, Mathew R: Caveolin-1 expression during the progression of pulmonary hypertension. Exp Biol Med (Maywood) 2012;237:956-965.
19. Patel HH, Zhang S, Murray F, Suda RY, Head BP, Yokoyama U, Swaney JS, Niesman IR, Schermuly RT, Pullamsetti SS, Thistlethwaite PA, Miyanohara A, Farquhar MG, Yuan JX, Insel PA: Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J 2007;21:2970-2979.
20. Burgermeister E, Liscovitch M, Rocken C, Schmid RM, Ebert MP: Caveats of caveolin-1 in cancer progression. Cancer Lett 2008;268:187-201.
21. Shaw L, Sweeney MA, O'Neill SC, Jones CJ, Austin C, Taggart MJ: Caveolae and sarcoplasmic reticular coupling in smooth muscle cells of pressurised arteries: The relevance for ca2+ oscillations and tone. Cardiovasc Res 2006;69:825-835.
22. Ushio-Fukai M, Zuo L, Ikeda S, Tojo T, Patrushev NA, Alexander RW: Cabl tyrosine kinase mediates reactive oxygen species-and caveolin-dependent at1 receptor signaling in vascular smooth muscle: Role in vascular hypertrophy. Circ Res 2005;97:829-836.
23. Bergdahl A, Gomez MF, Dreja K, Xu SZ, Adner M, Beech DJ, Broman J, Hellstrand P, Sward K: Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on trpc1. Circ Res 2003;93:839-847.
24. Zhang N, Ji Z: Effects of caveolin-1 and p-erk1/2 on ang ii-induced glomerular mesangial cell proliferation. Ren Fail 2013;35:971-977.
25. Fridolfsson HN, Patel HH: Caveolin and caveolae in age associated cardiovascular disease. J Geriatr Cardiol 2013;10:66-74.
26. Liu XR, Liu Q, Chen GY, Hu Y, Sham JS, Lin MJ: Down-regulation of trpm8 in pulmonary arteries of pulmonary hypertensive rats. Cell Physiol Biochem 2013;31:892-904.
27. Wang RX, He RL, Jiao HX, Dai M, Mu YP, Hu Y, Wu ZJ, Sham JS, Lin MJ: Ginsenoside rb1 attenuates agonist-induced contractile response via inhibition of store-operated calcium entry in pulmonary arteries of normal and pulmonary hypertensive rats. Cell Physiol Biochem 2015;35:1467-1481.
28. Wang J, Shimoda LA, Weigand L, Wang W, Sun D, Sylvester JT: Acute hypoxia increases intracellular [Ca2+] in pulmonary arterial smooth muscle by enhancing capacitative Ca2+ entry. Am J Physiol Lung Cell Mol Physiol 2005;288:L1059-1069.
29. Kawanabe Y, Nauli SM: Involvement of extracellular Ca2+ influx through voltage-independent Ca2+ channels in endothelin-1 function. Cell Signal 2005;17:911-916.
30. Shao D, Park JE, Wort SJ: The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension. Pharmacol Res 2011;63:504-511.
31. Schach C, Firth AL, Xu M, Remillard CV, Patel HH, Insel PA, Yuan JX: Regulation of pulmonary vasoconstriction by agonists and caveolae. Exp Lung Res 2008;34:195-208.
32. Peng G, Lu W, Li X, Chen Y, Zhong N, Ran P, Wang J: Expression of store-operated Ca2+ entry and transient receptor potential canonical and vanilloid-related proteins in rat distal pulmonary venous smooth muscle. Am J Physiol Lung Cell Mol Physiol 2010;299:L621-630.
33. Ju YK, Chu Y, Chaulet H, Lai D, Gervasio OL, Graham RM, Cannell MB, Allen DG: Store-operated Ca2+ influx and expression of trpc genes in mouse sinoatrial node. Circ Res 2007;100:1605-1614.
34. Lin MJ, Leung GP, Zhang WM, Yang XR, Yip KP, Tse CM, Sham JS: Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: A novel mechanism of hypoxic pulmonary hypertension. Circ Res 2004;95:496-505.
35. Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J, Agostinis P: Role of endoplasmic reticulum depletion and multidomain proapoptotic bax and bak proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J 2006;20:756-758.
36. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC: In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 2000;6:1362-1367.
37. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, Sessa WC: Reconstitution of an endothelial nitric-oxide synthase (enos), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of enos from caveolin-1. J Biol Chem 2000;275:22268-22272.
38. Yu X, Li T, Liu X, Yu H, Hao Z, Chen Y, Zhang C, Liu Y, Li Q, Mao M, Zhu D: Modulation of pulmonary vascular remodeling in hypoxia: Role of 15-lox-2/15-hete-mapks pathway. Cell Physiol Biochem 2015;35:2079-2097.
39. Li L, Xu M, Li X, Lv C, Zhang X, Yu H, Zhang M, Fu Y, Meng H, Zhou J: Platelet-derived growth factor-b (pdgf-b) induced by hypoxia promotes the survival of pulmonary arterial endothelial cells through the pi3k/akt/stat3 pathway. Cell Physiol Biochem 2015;35:441-451.
40. George MG, Schieb LJ, Ayala C, Talwalkar A, Levant S: Pulmonary hypertension surveillance: United states, 2001 to 2010. Chest 2014;146:476-495.
41. Rosenblum WD: Pulmonary arterial hypertension: Pathobiology, diagnosis, treatment, and emerging therapies. Cardiol Rev 2010;18:58-63.
42. Pavlides S, Gutierrez-Pajares JL, Iturrieta J, Lisanti MP, Frank PG: Endothelial caveolin-1 plays a major role in the development of atherosclerosis. Cell Tissue Res 2014;356:147-157.
43. Yi SL, Liu XJ, Zhong JQ, Zhang Y: Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts. PLoS One 2014;9:e85144.
44. Mathew R, Huang J, Katta US, Krishnan U, Sandoval C, Gewitz MH: Immunosuppressant-induced endothelial damage and pulmonary arterial hypertension. J Pediatr Hematol Oncol 2011;33:55-58.
45. Pani B, Liu X, Bollimuntha S, Cheng KT, Niesman IR, Zheng C, Achen VR, Patel HH, Ambudkar IS, Singh BB: Impairment of trpc1-stim1 channel assembly and aqp5 translocation compromise agonist-stimulated fluid secretion in mice lacking caveolin1. J Cell Sci 2013;126:667-675.
46. Lee MH, Chen SJ, Tsao CM, Wu CC: Perivascular adipose tissue inhibits endothelial function of rat aortas via caveolin-1. PLoS One 2014;9:e99947.
47. Lei L, Lu S, Wang Y, Kim T, Mehta D, Wang Y: The role of mechanical tension on lipid raft dependent pdgf-induced trpc6 activation. Biomaterials 2014;35:2868-2877.
48. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: Dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4:517-529.
49. Liu XR, Zhang MF, Yang N, Liu Q, Wang RX, Cao YN, Yang XR, Sham JS, Lin MJ: Enhanced store-operated Ca2+ entry and trpc channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Cell Physiol 2012;302:C77-87.
50. Sathish V, Thompson MA, Bailey JP, Pabelick CM, Prakash YS, Sieck GC: Effect of proinflammatory cytokines on regulation of sarcoplasmic reticulum ca2+ reuptake in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2009;297:L26-34.
51. Prakash YS, Thompson MA, Vaa B, Matabdin I, Peterson TE, He T, Pabelick CM: Caveolins and intracellular calcium regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007;293:L1118-1126.
52. Hassan GS, Williams TM, Frank PG, Lisanti MP: Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. Am J Physiol Heart Circ Physiol 2006;290:H2393-2401.
53. Rathor N, Chung HK, Wang SR, Wang JY, Turner DJ, Rao JN: Caveolin-1 enhances rapid mucosal restitution by activating trpc1-mediated Ca2+ signaling. Physiol Rep DOI:10.14814/phy2.12193.
54. Li X, Xing W, Wang Y, Mi C, Zhang Z, Ma H, Zhang H, Gao F: Upregulation of caveolin-1 contributes to aggravated high-salt diet-induced endothelial dysfunction and hypertension in type 1 diabetic rats. Life Sci 2014; 113: 31-39.
55. Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP: Caveolin-1 deficiency increases cerebral ischemic injury. Circ Res 2007;100:721-729.
56. Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP: Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 2011;300:H1274-1281.
57. Chen F, Barman S, Yu Y, Haigh S, Wang Y, Black SM, Rafikov R, Dou H, Bagi Z, Han W, Su Y, Fulton DJ: Caveolin-1 is a negative regulator of nadph oxidase-derived reactive oxygen species. Free Radic Biol Med 2014;73:201-213.
58. Quest AF, Gutierrez-Pajares JL, Torres VA: Caveolin-1: An ambiguous partner in cell signalling and cancer. J Cell Mol Med 2008;12:1130-1150.
59. Sharma P, Ghavami S, Stelmack GL, McNeill KD, Mutawe MM, Klonisch T, Unruh H, Halayko AJ: Beta-dystroglycan binds caveolin-1 in smooth muscle: A functional role in caveolae distribution and Ca2+ release. J Cell Sci 2010;123:3061-3070.
60. Zicha J, Behuliak M, Pinterova M, Bencze M, Kunes J, Vaneckova I: The interaction of calcium entry and calcium sensitization in the control of vascular tone and blood pressure of normotensive and hypertensive rats. Physiol Res 2014;63:S19-27.
61. Liu H, Chen M, Wu F, Li F, Yin T, Cheng H, Li W, Liu B, Wang Q, Tao L: Rs2910164 polymorphism confers a decreased risk for pulmonary hypertension by compromising the processing of microrna-146a. Cell Physiol Biochem 2015;36:1951-1960.
62. Zhou S, Li M, Zeng D, Xu X, Fei L, Zhu Q, Zhang Y, Wang R: A single nucleotide polymorphism in 3' untranslated region of epithelial growth factor receptor confers risk for pulmonary hypertension in chronic obstructive pulmonary disease. Cell Physiol Biochem 2015;36:166-178.
63. Jiang X, Yuan L, Li P, Wang J, Wang P, Zhang L, Sun B, Sun W: Effect of simvastatin on 5-ht and 5-htt in a rat model of pulmonary artery hypertension. Cell Physiol Biochem 2015;37:1712-1724.